Curanex Net Debt from 2010 to 2026
| CURX Stock | 0.30 0.02 7.14% |
Net Debt | First Reported 2010-12-31 | Previous Quarter -134 K | Current Value -140.7 K | Quarterly Volatility 26.4 K |
Check Curanex Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Curanex Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 K, Selling General Administrative of 350.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 5.2 K, Dividend Yield of 0.0 or PTB Ratio of 242. Curanex financial statements analysis is a perfect complement when working with Curanex Pharmaceuticals Valuation or Volatility modules.
Curanex | Net Debt | Build AI portfolio with Curanex Stock |
The evolution of Net Debt for Curanex Pharmaceuticals Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Curanex Pharmaceuticals compares to historical norms and industry peers.
Latest Curanex Pharmaceuticals' Net Debt Growth Pattern
Below is the plot of the Net Debt of Curanex Pharmaceuticals Common over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Curanex Pharmaceuticals' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Curanex Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Debt | 10 Years Trend |
|
Net Debt |
| Timeline |
Curanex Net Debt Regression Statistics
| Arithmetic Mean | (86,160) | |
| Coefficient Of Variation | (30.63) | |
| Mean Deviation | 19,425 | |
| Median | (74,366) | |
| Standard Deviation | 26,394 | |
| Sample Variance | 696.6M | |
| Range | 74.5K | |
| R-Value | (0.65) | |
| Mean Square Error | 425M | |
| R-Squared | 0.43 | |
| Significance | 0 | |
| Slope | (3,420) | |
| Total Sum of Squares | 11.1B |
Curanex Net Debt History
Other Fundumenentals of Curanex Pharmaceuticals
Curanex Pharmaceuticals Net Debt component correlations
Click cells to compare fundamentals
About Curanex Pharmaceuticals Financial Statements
Curanex Pharmaceuticals investors use historical fundamental indicators, such as Curanex Pharmaceuticals' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Curanex Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Debt | -134 K | -140.7 K | |
| Net Debt To EBITDA | 0.59 | 0.56 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Curanex Stock Analysis
When running Curanex Pharmaceuticals' price analysis, check to measure Curanex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curanex Pharmaceuticals is operating at the current time. Most of Curanex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Curanex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curanex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Curanex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.